Used in pharmaceutical research as a chiral building block for the synthesis of neuroactive compounds. It serves as an intermediate in the development of nicotinic acetylcholine receptor modulators, which are investigated for treating neurological disorders such as Alzheimer's disease, schizophrenia, and depression. Its structural configuration supports high receptor selectivity, making it valuable in optimizing drug efficacy and reducing side effects. Also employed in asymmetric synthesis due to its stereochemical stability and ability to direct enantioselective transformations.